| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |